Biophore India Pharmaceuticals has received license from Medicines Patent Pool (MPP) on behalf of originator company MSD, a trade name of Merck & Co., Inc, Kenilworth, New Jersey, USA, to manufacture ...

Akums Drugs & Pharmaceuticals currently manufactures around 12% of the country’s total medicinal requirements in the country. The organization deals in the manufacturing and export of formulations in ...

Zydus Cadila said the drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad. (Representational image) Biophore India Pharmaceuticals on Friday said it has ...

Hyderabad: Hyderabad-based Biophore India Pharmaceuticals on Friday said it has sought emergency use approval (EUA) from the Drugs Controller General of India (DCGI) for Aviptadil inhalation for the ...

The company has submitted results from multiple trials of Aviptadil for observing its role in recovery in Covid-19 patients with respiratory failure to the DCGI for review. The company has submitted ...

Biophore India Pharmaceuticals on Thursday announced that it has received license from Medicines Patent Pool (MPP) on behalf of originator company MSD, a trade name of Merck to manufacture and market ...

Hyderabad: City-based pharma player Biophore India Pharmaceuticals on Tuesday said it has received approval from Drug Controller General of India (DCGI) to manufacture the active pharmaceutical ...

Hyderabad: Biophore India Pharmaceuticals on Friday announced that it has applied for an emergency use approval of Aviptadil Inhalation to the Drugs Controller General of India (DCGI) for marketing ...

Contract drug manufacturing organisation (CDMO) major Akums Drugs and Pharmaceuticals Ltd has announced partnership with Leiutis Pharmaceuticals LLP and Biophore India Pharmaceuticals for research and ...

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to ...

Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to ...

Favipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid) virus, the influenza virus. Biophore India Pharmaceuticals, ...